Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

What are 10K annual reports?

10K reports are comprehensive annual reports filed by public companies with the SEC, containing detailed financial statements, business operations, risk factors, and management discussion.

How often are annual reports updated?

Annual reports are typically filed once per year, usually within 60-90 days after the company's fiscal year end. We update our database as soon as new reports become available.

How do I analyze AKTX stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate AKTX investment potential.

What is AKTX stock price today?

Get real-time AKTX stock price, historical data, and price charts on Financhill. Track AKTX performance with our advanced analysis tools.

Is AKTX a good investment?

Evaluate AKTX investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy AKTX stock?

To buy AKTX stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of AKTX?

View detailed market capitalization data and company valuation metrics for AKTX on our comprehensive analysis page.

What is the P/E ratio of AKTX?

Use our fundamental analysis tools to view AKTX P/E ratio and compare valuation metrics with industry peers.

What are AKTX earnings?

View AKTX earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Akari Therapeutics Plc 10K Form

Sell

AKTX
Akari Therapeutics Plc

Last Price:

$0.34

Seasonality Move:

-24.17%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2016-05-12	10Q	AKTX/Akari Therapeutics Plc Quarterly
2016-03-23	10K	AKTX/Akari Therapeutics Plc Annual

Receive AKTX News And Ratings

See the #1 stock for the next 7 days that we like better than AKTX

AKTX Financial Statistics

Sales & Book Value

Annual Sales:	$0
Cash Flow:	$-2.1M
Price / Cash Flow:	0
Annual Sales:	$0.70
Price / Book:	0.54

Profitability

EPS (TTM):	-0.39140
Net Income (TTM):	$-15.7M
Gross Margin:	$-14K
Return on Equity:	-92.06%
Return on Assets:	-39.27%

Akari Therapeutics Plc Earnings Forecast

Key Akari Therapeutics Plc Financial Ratios

Per Share Earnings over the last 15 years have been positive in 10 years.

Akari Therapeutics Plc Stock Price Chart

Industry, Sector and Symbol

Stock Exchange:	NASDAQ
Industry:	Biotechnology
Sector:	Health Care
Current Symbol:	AKTX
CUSIP:	00972G
Website:	akaritx.com

Debt

Debt-to-Equity Ratio:	0.09
Current Ratio:	0.19
Quick Ratio:	0.16

Price-to-Earnings

Trailing P/E Ratio:	0
Forward P/E Ratio:	0

AKTX Technical Analysis vs Fundamental Analysis